These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 19685465)

  • 41. Biotech holds its own in Q2.
    Lawrence S
    Nat Biotechnol; 2004 Aug; 22(8):938. PubMed ID: 15286634
    [No Abstract]   [Full Text] [Related]  

  • 42. Production and use of lignocellulosic bioethanol in Europe: Current situation and perspectives.
    Gnansounou E
    Bioresour Technol; 2010 Jul; 101(13):4842-50. PubMed ID: 20194021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of input-output analysis of energy and ecologic systems. In the early development of ecological economics--a personal perspective.
    Hannon B
    Ann N Y Acad Sci; 2010 Jan; 1185():30-8. PubMed ID: 20146760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Little biotech on the prairie.
    Wolfson W
    Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
    [No Abstract]   [Full Text] [Related]  

  • 45. Materials exchange deal meager boost to India's biotech.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1031. PubMed ID: 16151380
    [No Abstract]   [Full Text] [Related]  

  • 46. Taiwan: Biotech vision.
    Cyranoski D
    Nat Biotechnol; 2003 Apr; 21(4):463-4. PubMed ID: 12665831
    [No Abstract]   [Full Text] [Related]  

  • 47. John McCamant on the future of biotech. Interview by Dennis Murray.
    McCamant J
    Med Econ; 2002 Jan; 79(1):43-6. PubMed ID: 11807995
    [No Abstract]   [Full Text] [Related]  

  • 48. External benefits of biomass-e in Spain: an economic valuation.
    Soliño M
    Bioresour Technol; 2010 Mar; 101(6):1992-7. PubMed ID: 19900807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioethanol needs biotech now.
    Nat Biotechnol; 2006 Jul; 24(7):725. PubMed ID: 16841037
    [No Abstract]   [Full Text] [Related]  

  • 50. Biotech venture capital--it's not too late to be early.
    Klausner A
    Nat Biotechnol; 2005 Apr; 23(4):417-8. PubMed ID: 15815662
    [No Abstract]   [Full Text] [Related]  

  • 51. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E
    Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
    [No Abstract]   [Full Text] [Related]  

  • 52. Biotech equities heat up in 1Q12.
    Yang W
    Nat Biotechnol; 2012 May; 30(5):384. PubMed ID: 22565955
    [No Abstract]   [Full Text] [Related]  

  • 53. Icelandic biotech feels the pinch.
    Wadman M
    Nature; 2008 Oct; 455(7215):842. PubMed ID: 18938257
    [No Abstract]   [Full Text] [Related]  

  • 54. Biotech holds steady in Q4.
    Mitchell P
    Nat Biotechnol; 2004 Feb; 22(2):135-6. PubMed ID: 14755275
    [No Abstract]   [Full Text] [Related]  

  • 55. Early-stage returns?
    Booth BL
    Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Science in the meltdown.
    Waldrop MM
    Nature; 2008 Nov; 456(7219):155-9. PubMed ID: 19005526
    [No Abstract]   [Full Text] [Related]  

  • 57. Biotech R&D still reeling.
    Lawrence S
    Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
    [No Abstract]   [Full Text] [Related]  

  • 58. The changing norms of the life sciences.
    Shorett P; Rabinow P; Billings PR
    Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
    [No Abstract]   [Full Text] [Related]  

  • 59. Current status of biodiesel development in Brazil.
    Ramos LP; Wilhelm HM
    Appl Biochem Biotechnol; 2005; 121-124():807-19. PubMed ID: 15930560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Forming an international biotechnology spinout: is it worth it?
    Christoffersen RE
    Nat Biotechnol; 1999 Feb; 17 Suppl():BE20-1. PubMed ID: 10052319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.